§1275 — Title 15 Commerce and Trade | U.S. Code

Summary

Requires the Commission to create a Toxicological Advisory Board within 180 days after November 10, 1978, to give scientific advice about warning labels for dangerous substances. The Board must focus on three label parts: what safety steps to take, what hazards the product has, and first-aid instructions. It also advises on when a substance can be left out of the labeling rules. The Board must review any existing label rules and send recommended changes to the Commission within one year of being set up, and it must regularly check and update its advice as science changes. The Board has nine members picked by the Commission. Members must have the right training and experience, and at least three must belong to the American Board of Medical Toxicology. The Board elects its chair. Members serve three-year terms and can be reappointed. Vacancies are filled the same way as the original appointment. The Board must meet at least twice a year. Nonfederal members may be paid up to the daily equivalent of GS‑18 basic pay under section 5332 of title 5 and get travel expenses like intermittent government workers under section 5703(b) of title 5. Receiving these payments does not make them federal employees. The Board ends six years after it is established.

Title 15, §1275

Commerce and Trade — Source: USLM XML via OLRC

(a)(1)Within 180 days after November 10, 1978, the Commission shall establish, in accordance with subsection (b), a Toxicological Advisory Board (hereinafter in this section referred to as the “Board”) to advise the Commission on precautionary labeling for hazardous substances. The Board shall provide scientific and technical advice to the Commission concerning—

(A)proper labeling under section 1261(p)(1) and 1262(b) of this title, with special attention to—

(i)the description of precautionary measures required under section 1261(p)(1)(F) of this title;

(ii)the statement describing the hazards associated with a hazardous substance as required under section 1261(p)(1)(E) of this title; and

(iii)instructions for first-aid treatment under section 1261(p)(1)(G) of this title; and

(B)the exemption of certain substances from labeling requirements under this chapter as permitted under section 1262(c) of this title.

(2)In carrying out its duties under paragraph (1)(A), the Board shall review any labeling requirements or guidelines which have been established by the Commission under section 1261(p)(1) or 1262(b) of this title. Based upon its review the Board shall develop and submit to the Commission, within one year after the date that the Board is established, any recommendations for revisions in such labeling requirements or guidelines which the Board considers to be appropriate, including any general recommendations which may be of assistance to the Commission in carrying out its responsibilities under section 1261(p)(1) or 1262(b) of this title. The Board shall periodically review the labeling requirements and guidelines established by the Commission under such sections to determine whether such requirements and guidelines reflect relevant changes in scientific knowledge and shall revise any general recommendations submitted to the Commission under this paragraph to reflect such changes.

(b)(1)The Board shall be composed of nine members appointed by the Commission. Each member of the Board shall be qualified by training and experience in one or more fields applicable to the duties of the Board, and at least three of the members of the Board shall be members of the American Board of Medical Toxicology. The Chairman of the Board shall be elected by the Board from among its members.

(2)The members of the Board shall be appointed for terms of three years. Members of the Board may be reappointed.

(3)Any vacancy in the Board shall be filled in the same manner in which the original appointment was made. Any member appointed to fill a vacancy occurring before the expiration of the term for which his predecessor was appointed shall serve only for the remainder of such term.

(4)The Board shall meet at such times and places as may be designated by the Commission in consultation with the Chairman, but not less than two times each year.

(5)Members of the Board who are not officers or employees of the United States shall, while attending meetings or conferences of the Board or while otherwise engaged in the business of the Board, be entitled to receive compensation at a rate fixed by the Commission, not exceeding the daily equivalent of the annual rate of basic pay payable for grade GS–18 of the General Schedule under section 5332 of title 5. While away from their homes or regular places of business, such members may be allowed travel expenses, including per diem in lieu of subsistence, in the same manner as persons employed intermittently in the Government service are allowed under section 5703(b) 11 See References in Text note below. of such title. Individuals serving as members on the Board shall not be considered officers or employees of the United States by reason of receiving payments under this paragraph.

(c)The Board shall terminate on the date six years after the date it is established under this section.

Notes & Related Subsidiaries

Editorial Notes

References in Text

Section 5703 of title 5, referred to in subsec. (b)(5), was amended generally by Pub. L. 94–22, § 4, May 19, 1975, 89 Stat. 85, and, as so amended, does not contain a subsec. (b).

Amendments

2008—Subsec. (a)(1). Pub. L. 110–314 substituted “Commission” for “Consumer Product Safety Commission” after “November 10, 1978, the” and struck out “(hereinafter in this section referred to as the ‘Commission’)” immediately thereafter.

Statutory Notes and Related Subsidiaries

References in Other Laws to GS–16, 17, or 18 Pay RatesReferences in laws to the rates of pay for GS–16, 17, or 18, or to maximum rates of pay under the General Schedule, to be considered references to rates payable under specified sections of Title 5, Government Organization and Employees, see section 529 [title I, § 101(c)(1)] of Pub. L. 101–509, set out in a note under section 5376 of Title 5.

§1275 Toxicological Advisory Board